Skip to main content

Juan F. Granada, MD

12/09/2009
What is unique about the vProtect™ Luminal Shield? This stent is part of a new generation of self-expandable nitinol stents. In this particular stent design, the radial force has been calculated to achieve less chronic outward force — an...
What is unique about the vProtect™ Luminal Shield? This stent is part of a new generation of self-expandable nitinol stents. In this particular stent design, the radial force has been calculated to achieve less chronic outward force — an...
What is unique about the...
12/09/2009
Cath Lab Digest
CLI Perspectives
09/05/2016
In this issue, we are shifting gears to address inflow for the critical limb ischemia patient, and discuss primarily superficial femoral artery (SFA) and popliteal issues.
In this issue, we are shifting gears to address inflow for the critical limb ischemia patient, and discuss primarily superficial femoral artery (SFA) and popliteal issues.
In this issue, we are shifting...
09/05/2016
Cath Lab Digest
CLI Perspectives
09/07/2015
CLI Perspectives is headed by section editor J.A. Mustapha, MD, Metro Health Hospital, Wyoming, Michigan. 
CLI Perspectives is headed by section editor J.A. Mustapha, MD, Metro Health Hospital, Wyoming, Michigan. 
CLI Perspectives is headed by...
09/07/2015
Cath Lab Digest
CRF-SKIRBALL Interventional Innovation Corner
01/10/2017
Interventional heart failure is a field that has been growing very fast over the last decade. It has been around for quite some time, particularly with the development of left ventricular assist devices (LVADs), but as catheter-based...
Interventional heart failure is a field that has been growing very fast over the last decade. It has been around for quite some time, particularly with the development of left ventricular assist devices (LVADs), but as catheter-based...
Interventional heart failure is...
01/10/2017
Cath Lab Digest
CRF-SKIRBALL Interventional Innovation Corner
10/06/2016
Several years ago, inspired by the fact that we receive so many applications to present innovation at TCT, we decided to separate innovation from mainstream education and hold dedicated sessions in order to display the best innovative...
Several years ago, inspired by the fact that we receive so many applications to present innovation at TCT, we decided to separate innovation from mainstream education and hold dedicated sessions in order to display the best innovative...
Several years ago, inspired by...
10/06/2016
Cath Lab Digest
CRF-SKIRBALL Interventional Innovation Corner
05/02/2016
Over the last decade, we have observed the natural confluence of digital technologies and healthcare, and this trend will only continue to expand over time. The most exciting aspect of this new technological revolution is how patients are...
Over the last decade, we have observed the natural confluence of digital technologies and healthcare, and this trend will only continue to expand over time. The most exciting aspect of this new technological revolution is how patients are...
Over the last decade, we have...
05/02/2016
Cath Lab Digest
CRF-SKIRBALL Interventional Innovation Corner
01/31/2016
Bioresorbable scaffolds (BRS) are emerging as an alternative approach to metallic DES due to their ability to mechanically support coronary arteries in the early phase post intervention, followed by complete absorption of the scaffold over...
Bioresorbable scaffolds (BRS) are emerging as an alternative approach to metallic DES due to their ability to mechanically support coronary arteries in the early phase post intervention, followed by complete absorption of the scaffold over...
Bioresorbable scaffolds (BRS)...
01/31/2016
Cath Lab Digest
Feature Interview
07/14/2016
This month, interventional cardiologist Peter J. Fitzgerald, MD, PhD, Professor, Medicine - Cardiovascular Medicine; Professor (by courtesy), Electrical Engineering; Director, Center for Cardiovascular Technology and Innovation and Director,...
This month, interventional cardiologist Peter J. Fitzgerald, MD, PhD, Professor, Medicine - Cardiovascular Medicine; Professor (by courtesy), Electrical Engineering; Director, Center for Cardiovascular Technology and Innovation and Director,...
This month, interventional...
07/14/2016
EP Lab Digest
Tips and Techniques
05/05/2017
Local drug delivery is rapidly emerging as the first line of therapy for the interventional treatment of superficial femoral artery disease. Paclitaxel-eluting drug-coated balloons are emerging as a promising therapy.
Local drug delivery is rapidly emerging as the first line of therapy for the interventional treatment of superficial femoral artery disease. Paclitaxel-eluting drug-coated balloons are emerging as a promising therapy.
Local drug delivery is rapidly...
05/05/2017
Vascular Disease Management